Celsius Holdings Q2 EPS $0.05 Beats $0.02 Estimate, Sales $65.07M Beat $53.47M Estimate
Celsius Holdings (NASDAQ: CELH) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.02 by 150 percent.
Recap: Celsius Holdings Q2 Earnings
Shares of Celsius Holdings (NASDAQ:CELH) rose 0.2% in pre-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were up 150.00% over the past year to $0.05, which beat the estimate of $0.02.
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell
• Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
Why Jonah Lupton Is Pumped Up For Celsius Holdings
Jonah Lupton of Lupton Capital sipped on a Celsius Holdings Inc (NASDAQ: CELH) beverage Friday with Benzinga "Power Hour" host Luke Jacobi and talked about the upside he sees in the stock.
Cramer Weighs In On Senseonics Holdings, Celsius And Contextlogic
On CNBC's "Mad Money Lightning Round," Jim Cramer said Senseonics Holdings Inc (NYSE: SENS) competes with DexCom, Inc. (NASDAQ:
10 Biggest Price Target Changes For Friday
Barclays lowered Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) price target from $302 to $285. Vertex Pharmaceuticals shares fell 13.3% to $187.88 in pre-market trading.
Credit Suisse Upgrades Celsius Holdings to Outperform, Raises Price Target to $78
Credit Suisse analyst Kaumil Gajrawala upgrades Celsius Holdings (NASDAQ:CELH) from Neutral to Outperform and raises the price target from $57 to $78.
